Luminex adds to molecular Dx offering further with $50m GenturaDx buy
This article was originally published in Clinica
Executive Summary
Multiplexing firm Luminex has splashed out $50m to buy nucleic acid testing specialist GenturaDx, just over a year after it had bought EraGen Biosciences, a company also in the molecular diagnostics field.